诊断学理论与实践 ›› 2019, Vol. 18 ›› Issue (1): 56-60.doi: 10.16150/j.1671-2870.2019.01.011

• 论著 • 上一篇    下一篇

α7烟碱型乙酰胆碱受体激动剂对TGF-β1介导的血管外膜成纤维细胞表型转化影响的体外研究

魏坚1, 高平进2, 韩卫青2()   

  1. 1. 上海交通大学医学院附属瑞金医院检验科,上海 200025
    2. 上海市高血压研究所,上海 200025
  • 收稿日期:2018-09-20 出版日期:2019-02-25 发布日期:2019-02-25
  • 通讯作者: 韩卫青 E-mail:hanweiqing2000@163.com

Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro

WEI Jian1, GAO Pingjin2, HAN Weiqing2()   

  1. 1. Department of Clinical Laboratory, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China
    2. Shanghai Institute of Hypertension, Shanghai 200025, China
  • Received:2018-09-20 Online:2019-02-25 Published:2019-02-25
  • Contact: HAN Weiqing E-mail:hanweiqing2000@163.com

摘要: 目的 探讨α7烟碱型乙酰胆碱受体(α7 nicotinic acetylcholine receptor, α7 nAchR)与血管外膜成纤维细胞(adventitial fibroblasts, AF)表型转化间的关系。方法 选取雄性Sprague-Dawley(SD)大鼠,用组织切块法培养其胸主动脉外膜AF。为评估转化生长因子β1(transforming growth factor-β1, TGF-β1)刺激AF表型转化的作用,将体外培养的AF分为空白对照组A、TGF-β1处理24 h组和TGF-β1处理48 h组3组,处理结束后分别应用实时定量PCR和免疫印迹试验,检测相α7 nAchR基因和蛋白的表达以及α-肌动蛋白(α smooth muscle actin, α-SMA)和Ⅰ型胶原的表达情况。为进一步探讨α7 nAchR的激活能否抑制TGF-β1刺激表型转化及其分子机制,另将体外培养的AF分为空白对照组B、TGF-β1处理48 h组及TGF-β1处理48 h合并α7 nAchR激活剂PNU-282987处理组3组,处理48 h后用免疫印迹法检测α-SMA和Ⅰ型胶原的表达及细胞外调节蛋白激酶1/2(extracellular regulated protein kinases1/2, Erk1/2)磷酸化情况。结果 与空白对照A相比,TGF-β1可使α7 nAchR的基因和蛋白表达明显降低(P<0.05),同时TGF-β1可使α-SMA和Ⅰ型胶原的表达明显增加(P<0.05)。α7 nAchR激动剂PNU-282987可抑制TGF-β1刺激的AF中α-SMA和Ⅰ型胶原的表达,亦可抑制TGF-β1刺激的Erk1/2磷酸化。结论 α7 nAchR的抑制参与TGF-β1介导的血管AF表型转化,其机制可能与Erk1/2磷酸化有关。

关键词: α7烟碱型乙酰胆碱受体, 外膜成纤维细胞, 细胞表型转化, 机制

Abstract:

Objective: To investigate the correlation between α7 nicotinic acetylcholine receptor (α7 nAchR) and phenotypic transformation of adventitial fibroblasts (AF). Methods: AF were isolated and cultured by using thoracic aorta of male Sprague-Dawley (SD) rats. For evaluating the effect of transforming growth factor-β1 (TGF-β1) on phenotypic transformation of AF, cultured AF were divided into three groups: blank control group A, group with 24 h TGF-β1 treatment, and group with 48 h TGF-β1 treatment. After treatment, real-time quantitative PCR and western blotting were used to detect the mRNA level and protein level of α7 nAchR, and the expression of a smooth muscle actin (α-SMA) and collagen Ⅰ. To further explore whether the activation of α7 nAchR can inhibit TGF-β1-induced phenotypic transformation and the underlying molecular mechanism, AF cultured in vitro were divided into three groups: blank control group B, group with 48 h TGF-β1 treatment, and group with 48 h TGF-β1 +PNU-282987 (an α7 nAchR activator) treatment. After 48 h treatment, the expression of α-SMA and collagen Ⅰ and the phosphorylation of extracellular regulated protein kinase 1/2 (Erk1/2) were detected by immunoblotting. Results: Compared with the blank control group A, TGF-β1 significantly decreased the mRNA level and protein level of α7 nAchR (P<0.05), whereas TGF-β1 induced significant increase of a-SMA and collagen Ⅰ (P<0.05). PNU-282987, an α7 nAchR agonist, inhibited TGF-β1-induced expression of α-SMA and collagen typeⅠ. Meanwhile, PNU-282987 also significantly inhibited TGF-β1-induced Erk1/2 phosphorylation. Conclusions: The inhibition of α7 nAchR is involved in TGF-β1-induced phenotypic transformation in AF, and the mechanism may be related to Erk1/2 phosphorylation.

Key words: α7 nicotinic acetylcholine receptor, Adventitial fibroblasts, Cell phenotype transformation, Mechanism

中图分类号: